Benoît Vanderperre, PhD, obtained a BSc in molecular and cellular biology and an MSc in biosciences from the Ecole Normale Supérieure de Lyon, France. He then joined the laboratory of Xavier Roucou, PhD, at the University of Sherbrooke, Canada, where he completed his PhD in biochemistry in 2013. He received the 2013 Discovery of the Year award from Québec Science Magazine for his research in molecular genetics. He then joined the laboratory of Jean-Claude Martinou at the University of Geneva, Switzerland, where he studied mitochondria, cell's energy generators, and mitochondrial pyruvate carrier, a protein that plays an important role in metabolism. Since 2016, he has been working as a postdoctoral fellow in the laboratory of Edward Fon, MD, at McGill University, Canada. This work is supported by a fellowship from the Canadian Institutes for Health Research. Using stem cells and the CRISPR/Cas9 technology for gene editing, Dr. Vanderperre studies two processes that contribute to Parkinson's disease: cell-to-cell transmission of alpha-synuclein -- a sticky protein that clumps in the brains of people with PD -- and the dysfunction of lysosomes, cell's waste disposals.